Informe de análisis de tamaño, participación y tendencias del mercado mundial de gestión de enfermedades crónicas: descripción general de la industria y pronóstico hasta 2031

Análisis del mercado de gestión de enfermedades crónicas  

El mercado de gestión de enfermedades crónicas (CDM) está experimentando un crecimiento significativo, impulsado por la creciente prevalencia de enfermedades crónicas como diabetes, enfermedades cardiovasculares y trastornos respiratorios. Los avances en tecnología, en particular la integración de aplicaciones de telesalud y salud móvil, han transformado la forma en que los proveedores de atención médica brindan atención, haciéndola más accesible y eficiente. En los últimos años, han surgido varios desarrollos clave, como el lanzamiento de plataformas impulsadas por IA que mejoran el monitoreo de pacientes y el análisis de datos, lo que permite planes de atención personalizados adaptados a las necesidades individuales de los pacientes. Por ejemplo, las capacidades de análisis predictivo de WellSky dentro de su solución CarePort Connect facilitan las derivaciones oportunas para cuidados paliativos, lo que muestra el potencial de los enfoques basados ​​​​en datos en CDM. Además, las asociaciones entre organizaciones de atención médica y empresas de tecnología, como la colaboración entre Premier, Inc. y AstraZeneca, tienen como objetivo mejorar la conciencia y la gestión de la enfermedad renal crónica , lo que ilustra aún más el enfoque del mercado en estrategias de atención integral. En general, el mercado de CDM está preparado para el crecimiento, respaldado por soluciones innovadoras y un énfasis cada vez mayor en la gestión proactiva de la atención médica para mejorar los resultados de los pacientes y reducir los costos de la atención médica.

Tamaño del mercado de gestión de enfermedades crónicas

El tamaño del mercado mundial de gestión de enfermedades crónicas se valoró en USD 7,17 mil millones en 2023 y se proyecta que alcance los USD 24,01 mil millones para 2031, con una CAGR del 16,30% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Tendencias del mercado de gestión de enfermedades crónicas

“ Aumento de la adopción de tecnologías de salud digital”

The chronic disease management (CDM) market is experiencing significant growth, propelled by partnerships between healthcare organizations and tech companies. One prominent trend in the chronic disease management (CDM) market is the increasing adoption of digital health technologies, particularly telehealth and remote patient monitoring solutions. These technologies enhance patient engagement and empower individuals to take control of their health through continuous monitoring and timely interventions. For instance, companies such as WellSky are incorporating advanced predictive analytics into their CDM platforms, enabling healthcare providers to identify patients at risk of complications and facilitating early interventions. This shift towards digital solutions improves patient outcomes and  streamlines care coordination, reducing the burden on healthcare systems. Furthermore, as more patients prefer virtual consultations and remote monitoring, healthcare organizations are investing in user-friendly mobile applications that allow for real-time communication between patients and providers. This trend reflects the ongoing transformation of the CDM landscape, making chronic disease management more efficient and accessible while enhancing overall healthcare delivery.

Report Scope and Chronic Disease Management Market Segmentation         

Chronic Disease Management Market Definition

Chronic disease management refers to the coordinated, long-term care and support provided to individuals with chronic illnesses to help them manage their conditions effectively. Chronic diseases, such as diabetes, hypertension, heart disease, and asthma, often require continuous monitoring, medication adherence, lifestyle changes, and regular healthcare interventions. The goal of chronic disease management is to improve the patient's quality of life, reduce complications, prevent disease progression, and minimize the need for hospitalizations or emergency care through personalized treatment plans, education, and self-care strategies.

Chronic Disease Management Market Dynamics

Drivers

• Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases globally has significantly boosted the demand for CDM services and solutions. For instance, the World Health Organization reported that chronic diseases are responsible for 71% of all deaths globally, emphasizing the need for effective management strategies. CDM aids in medication adherence and enhances overall patient care by providing tailored resources, educational materials, and support systems. Such holistic approach helps individuals better understand their conditions, leading to improved self-management and health outcomes. Consequently, as the incidence rates of chronic diseases continue to rise, the demand for comprehensive CDM solutions is anticipated to grow, driving market expansion and innovation in healthcare delivery systems.

• Growing Geriatric Population

Aging is a significant risk factor for numerous chronic diseases, making the geriatric population a critical demographic in healthcare. Older adults typically require more medical services compared to younger adults, as they often suffer from a range of chronic health issues, including diabetes, hypertension, and heart disease. For instance, according to the Centers for Disease Control and Prevention (CDC), about 80% of older adults have at least one chronic condition, and 68% have two or more. Such high prevalence positions older adults as the primary users of Chronic Disease Management (CDM) services and solutions, which are tailored to address their unique healthcare needs. As the global geriatric population continues to grow expected to reach approximately 1.5 billion by 2050 the demand for effective CDM services is anticipated to escalate. This trend underscores the importance of developing specialized solutions for this demographic and drives significant market growth as healthcare systems adapt to meet the increasing needs of aging individuals.

Opportunities

• Surge in Novel Technological Advancements

Chronic diseases have emerged as one of the leading causes of death in emerging economies and developing countries, prompting a heightened focus on chronic disease management (CDM) among public health practitioners. For instance, according to the World Health Organization (WHO), chronic diseases account for nearly 60% of deaths in low- and middle-income countries. The integration of advanced technologies has revolutionized the management of chronic conditions such as asthma, arthritis, and diabetes, ensuring that patients are no longer treated in isolation. Innovative healthcare monitoring applications and devices, such as wearable fitness trackers and mobile health apps, have significantly improved communication between patients and healthcare providers. These tools facilitate real-time updates to treatment plans, leading to better health outcomes.  Such technological evolution creates a substantial opportunity for market growth, as healthcare systems increasingly adopt CDM solutions to enhance patient care and overall health outcomes in managing chronic diseases.

• Rising Healthcare Expenditure

Rising healthcare expenditure globally presents a significant opportunity for the chronic disease management (CDM) market, as governments and private sectors allocate more funds toward improving healthcare services and technologies. According to the World Bank, global health expenditure reached approximately 9.8% of the world's GDP in 2020, reflecting a growing commitment to health infrastructure and services. Increased spending on healthcare often translates to enhanced funding for CDM solutions that facilitate better management of chronic diseases. For instance, the introduction of innovative telehealth platforms allows healthcare providers to monitor patients remotely, reducing hospital visits and improving access to care. As healthcare budgets continue to expand, investments in CDM technologies are likely to rise, fostering a more robust market environment focused on enhancing patient outcomes and managing chronic illnesses effectively.

Restraints/Challenges

• Data Privacy and Security Concerns

Data privacy and security concerns pose significant challenges for the chronic disease management (CDM) market, particularly with the growing reliance on digital tools and telehealth platforms. As healthcare providers adopt these technologies to enhance patient care, the risk of data breaches and unauthorized access to sensitive patient information also escalates. For instance, a 2021 survey revealed that  in 2021, over 45 million patient medical records were affected by cyber threats, which was a significant increase from 2020. Compliance with regulations like the Health Insurance Portability and Accountability Act (HIPAA) adds another layer of complexity, as healthcare organizations must implement stringent security measures to protect patient data. Failure to adhere to these regulations can result in substantial fines and legal liabilities, deterring healthcare providers from fully embracing digital solutions for chronic disease management.

• High Costs of Implementation

High costs of implementation pose a significant challenge for establishing chronic disease management (CDM) programs, particularly for smaller healthcare providers with limited financial resources. The initial investment required for technology solutions, such as electronic health record (EHR) systems, telehealth platforms, and data analytics tools, can be substantial. For instance, a small clinic may face considerable startup expenses to integrate a comprehensive CDM solution, which includes purchasing software, training staff, and maintaining the system. In addition, ongoing operational costs, such as hiring specialized personnel and ensuring compliance with evolving regulations, further strain budgets. This financial burden can deter smaller healthcare organizations from adopting CDM programs, limiting access to vital services for patients with chronic conditions. Consequently, the high costs associated with implementing CDM initiatives can hinder overall market growth and patient care improvements

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Chronic Disease Management Market Scope

The market is segmented on the basis of type, disease indication, deployment types and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Solution
  • On-Premise Solution
  • Cloud-Based Solution
  • Web-Based
• Services
  • Educational Service
  • Implementation Service
  • Consulting Service
  • Others

Disease Indication

• Cardiovascular Diseases (CVD)
• Diabetes
• Chronic Obstructive Pulmonary Disorders (COPD)
• Arthritis
• Asthma
• Cancer
• Others

Deployment Types

• On-Premises
• Cloud-Based
• Web-Based

End User

• Healthcare Providers
• Healthcare Payers
• Others

Chronic Disease Management Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, disease indication, deployment types, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is poised to lead the global chronic disease management market, primarily driven by the rising elderly population that requires ongoing care and support for chronic conditions. The region's strong emphasis on technological advancements, such as telehealth and digital health tools, further enhances the effectiveness of chronic disease management strategies. In addition, the presence of key market players and their continuous innovation are expected to significantly boost the growth rate of the market in North America.

Asia-Pacific region is anticipated to experience significant growth in the chronic disease management (CDM) market from 2024 to 2031, driven by the rising availability of CDM providers that offer essential services to manage various chronic conditions. This growth is further supported by increasing healthcare investments and the implementation of policies aimed at enhancing access to healthcare facilities. Moreover, the region's expanding population and the growing prevalence of chronic diseases are likely to create a greater demand for effective CDM solutions, thereby contributing to the market's expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Chronic Disease Management Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Los líderes del mercado de gestión de enfermedades crónicas que operan en el mercado son:

• WellSky (Estados Unidos)
• ZeOmega (India)
• Catalizador de salud (EE. UU.)
• Cedar Gate Technologies (Estados Unidos)
• Cognizant (Estados Unidos)
• Pegasystems Inc. (Estados Unidos)
• Epic Systems Corporation (Estados Unidos)
• Soluciones globales de Hinduja Ltd. (India)
• NXGN Management, LLC (Estados Unidos)
• MINES & Associates, Inc. (Estados Unidos)
• Zyter (Estados Unidos)
• ExlServings Holdings, Inc. (Estados Unidos)
• Cliexa, Inc. (Estados Unidos)
• Corporación ScienceSoft USA (Estados Unidos)
• Optum, Inc. (Estados Unidos)
• Veradigm LLC (Estados Unidos)
• Infosys Limited (India)
• Medecision (Estados Unidos)
• IBM (Estados Unidos)
• Alianza de Planes de Salud (Estados Unidos)
• Servicios de consultoría TATA Limited (India)

Últimos avances en el mercado de la gestión de enfermedades crónicas

• En mayo de 2023, WellSky, una destacada empresa de tecnología en el ámbito de la salud y la atención comunitaria, presentó nuevas funciones de análisis predictivo en su solución CarePort Connect. Estas mejoras tienen como objetivo ayudar a los hospitales, los pagadores y los proveedores de atención postaguda a identificar de manera más eficaz a los pacientes que son aptos para recibir cuidados paliativos y facilitar derivaciones oportunas. Con una red de derivaciones que abarca 2000 hospitales en todo Estados Unidos, WellSky facilita más de 13 millones de altas hospitalarias al año y ahora está lanzando una innovadora red nacional de identificación de pacientes aptos para cuidados paliativos.
• En mayo de 2024, Premier, Inc. se complace en anunciar una asociación estratégica con AstraZeneca para la iniciativa Uncover CKD - ​​Care Collective. Esta colaboración tiene como objetivo identificar a los pacientes con enfermedad renal crónica (ERC) clínica no diagnosticada, mejorar la conciencia sobre la ERC no diagnosticada entre los proveedores de atención médica y guiar a los sistemas de salud de EE. UU. que buscan mejorar o establecer estrategias para el diagnóstico, el tratamiento y la gestión de la ERC.
• En enero de 2024, Eli Lilly and Company anunció el lanzamiento de LillyDirect, una nueva plataforma de atención médica digital diseñada para pacientes en los EE. UU. que padecen obesidad, migraña y diabetes. LillyDirect ofrece recursos para el manejo de enfermedades, incluido el acceso a proveedores de atención médica independientes, apoyo personalizado y entrega directa a domicilio de medicamentos seleccionados de Lilly a través de servicios de dispensación de farmacias de terceros.
• En noviembre de 2021, IBM presentó Imaging AI Orchestration, una solución innovadora diseñada para permitir que las organizaciones de diagnóstico por imágenes aprovechen todo el potencial de las aplicaciones de inteligencia artificial de manera cohesiva. Esta plataforma permite la integración perfecta de varias herramientas de IA, lo que mejora la eficiencia del flujo de trabajo y la precisión del diagnóstico en las imágenes médicas.
• En abril de 2021, WellSky presentó una solución de gestión avanzada para las visitas médicas a domicilio denominada CareInsights Guidance. Este innovador componente proporciona información útil sobre la utilización de las visitas, con el objetivo de optimizar la calidad del tratamiento y mejorar los resultados de salud del paciente. Se prevé que el lanzamiento de esta solución beneficie tanto a los pacientes como a los empleados, al tiempo que impulsa el crecimiento de las ventas de la empresa.

SKU-39216